| HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression … RK Gupta, J Gregson, N Parkin, H Haile-Selassie, A Tanuri, LA Forero, ... The Lancet infectious diseases 18 (3), 346-355, 2018 | 451 | 2018 |
| Recurrent potent human neutralizing antibodies to Zika virus in Brazil and Mexico DF Robbiani, L Bozzacco, JR Keeffe, R Khouri, PC Olsen, A Gazumyan, ... Cell 169 (4), 597-609. e11, 2017 | 359 | 2017 |
| Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study J Gregson, M Tang, N Ndembi, RL Hamers, SY Rhee, VC Marconi, ... The Lancet infectious diseases 16 (5), 565-575, 2016 | 305 | 2016 |
| Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient-and sequence-level meta-analysis SY Rhee, JL Blanco, MR Jordan, J Taylor, P Lemey, V Varghese, ... PLoS medicine 12 (4), e1001810, 2015 | 284 | 2015 |
| Pretreatment HIV-drug resistance in Mexico and its impact on the effectiveness of first-line antiretroviral therapy: a nationally representative 2015 WHO survey S Ávila-Ríos, C García-Morales, M Matías-Florentino, KA Romero-Mora, ... The lancet HIV 3 (12), e579-e591, 2016 | 113 | 2016 |
| Highly pathogenic avian influenza A (H7N3) virus in poultry workers, Mexico, 2012 I Lopez-Martinez, A Balish, G Barrera-Badillo, J Jones, TE Nuñez-García, ... Emerging infectious diseases 19 (9), 1531, 2013 | 109 | 2013 |
| Next-generation sequencing for HIV drug resistance testing: laboratory, clinical, and implementation considerations S Ávila-Ríos, N Parkin, R Swanstrom, R Paredes, R Shafer, H Ji, R Kantor Viruses 12 (6), 617, 2020 | 78 | 2020 |
| Acute kidney injury in patients with severe COVID-19 in Mexico GA Casas-Aparicio, I Leon-Rodriguez, C Alvarado-de la Barrera, ... Plos one 16 (2), e0246595, 2021 | 74 | 2021 |
| Dysbiosis and structural disruption of the respiratory microbiota in COVID-19 patients with severe and fatal outcomes A Hernández-Terán, F Mejía-Nepomuceno, MT Herrera, O Barreto, ... Scientific reports 11 (1), 21297, 2021 | 68 | 2021 |
| Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing ER Lee, N Parkin, C Jennings, CJ Brumme, E Enns, M Casadellà, ... Scientific reports 10 (1), 1634, 2020 | 67 | 2020 |
| Differential clade-specific HLA-B* 3501 association with HIV-1 disease outcome is linked to immunogenicity of a single Gag epitope PC Matthews, M Koyanagi, HN Kløverpris, M Harndahl, A Stryhn, ... Journal of virology 86 (23), 12643-12654, 2012 | 61 | 2012 |
| Clinical impact of pretreatment human immunodeficiency virus drug resistance in people initiating nonnucleoside reverse transcriptase inhibitor–containing antiretroviral … S Bertagnolio, L Hermans, MR Jordan, S Avila-Rios, C Iwuji, A Derache, ... The Journal of infectious diseases 224 (3), 377-388, 2021 | 57 | 2021 |
| Surveillance of HIV transmitted drug resistance in Latin America and the Caribbean: a systematic review and meta-analysis S Avila-Rios, O Sued, SY Rhee, RW Shafer, G Reyes-Teran, G Ravasi PloS one 11 (6), e0158560, 2016 | 57 | 2016 |
| Severe 2009 pandemic influenza A (H1N1) infection and increased mortality in patients with late and advanced HIV disease CE Ormsby, D de la Rosa-Zamboni, J Vázquez-Pérez, ... Aids 25 (4), 435-439, 2011 | 57 | 2011 |
| Activation of NK cells is associated with HIV-1 disease progression L Kuri-Cervantes, GSM de Oca, S Ávila-Ríos, R Hernández-Juan, ... Journal of leukocyte biology 96 (1), 7-16, 2014 | 53 | 2014 |
| Optic neuritis following SARS-CoV-2 infection MS Rodríguez-Rodríguez, RM Romero-Castro, C Alvarado-de la Barrera, ... Journal of neurovirology 27, 359-363, 2021 | 52 | 2021 |
| Profound phenotypic and epigenetic heterogeneity of the HIV-1-infected CD4+ T cell reservoir VH Wu, JML Nordin, S Nguyen, J Joy, F Mampe, PM del Rio Estrada, ... Nature immunology 24 (2), 359-370, 2023 | 51 | 2023 |
| Genomic analysis of early SARS-CoV-2 variants introduced in Mexico B Taboada, JA Vazquez-Perez, JE Muñoz-Medina, P Ramos-Cervantes, ... Journal of Virology 94 (18), 10.1128/jvi. 01056-20, 2020 | 51 | 2020 |
| Multi-laboratory comparison of next-generation to sanger-based sequencing for HIV-1 drug resistance genotyping NT Parkin, S Avila-Rios, DF Bibby, CJ Brumme, SH Eshleman, ... Viruses 12 (7), 694, 2020 | 48 | 2020 |
| Bioinformatic data processing pipelines in support of next‐generation sequencing‐based HIV drug resistance testing: the Winnipeg consensus H Ji, E Enns, CJ Brumme, N Parkin, M Howison, ER Lee, R Capina, ... Journal of the International AIDS Society 21 (10), e25193, 2018 | 47 | 2018 |
